Carpal Tunnel Syndrome (CTS)CTS+ PathwayNCT06717477
Streamlining Care for Patients With Compression Neuropathies: The Carpal Tunnel Plus Pathway
An observational study of Carpal Tunnel Syndrome (CTS), run by University of British Columbia at 1 site in Canada.
Trial summary
The goal of this clinical trial is to assess the impact of a new care pathway (the Carpal Tunnel Plus Pathway) in patients with carpal tunnel syndrome. The main questions it aims to answer are: 1. What was the effect of the Carpal Tunnel Plus Pathway on wait times between each step of the care pathway (e.g. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Carpal Tunnel Syndrome (CTS)
- What is being tested?
- Changes to the care pathway for carpal tunnel syndrome (The Carpal Tunnel Plus Pathway)
- Type of treatment
- Injection or infusion, Surgery or procedure
- How many people
- 200 participants
- Where
- 1 siteCanada
- Study dates
- 18 Feb 2025to Mar 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Retrospective: Patients age 18 or over seen by study surgeons for CTS. Prospective: patients age 18 or over with carpal tunnel syndrome seen at SPH or Vancouver Hospital EMG lab.
Who may be able to join
- 18 years of age or older
- Referred to the Vancouver General Hospital Neuromuscular Disease Unit or St. Paul's Hospital with a confirmed diagnosis of carpal tunnel syndrome
- Ability to understand English
Who cannot join
- Inability to provide informed consent
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
The goal of this clinical trial is to assess the impact of a new care pathway (the Carpal Tunnel Plus Pathway) in patients with carpal tunnel syndrome. The main questions it aims to answer are:
- What was the effect of the Carpal Tunnel Plus Pathway on wait times between each step of the care pathway (e.g. from referral to initial consult, from initial consult to surgical consult, etc.)?
- How satisfied are patients with the care they received through the Carpal Tunnel Plus Pathway?
Researchers will compare wait times pre- and post- Pathway implementation to see if there was any change.
Participants will be asked to complete a short patient satisfaction survey.
- Conditions
- Carpal Tunnel Syndrome (CTS)
- Being tested
- Changes to the care pathway for carpal tunnel syndrome (The Carpal Tunnel Plus Pathway)
- Keywords
- Carpal Tunnel Syndrome, Patient Satisfaction, Care Pathway
- Medical subject headings
- Carpal Tunnel Syndrome, Patient Satisfaction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Changes to the care pathway for carpal tunnel syndrome (The Carpal Tunnel Plus Pathway)Procedure or surgery
Changes to the care pathway for carpal tunnel syndrome. Features of the CTS+ pathway include new referral form, care map for mild, moderate and severe CTS established, point or care ultrasound with steroid injection introduced, and expedited referral to surgeons.
| Study group | Role | What they receive |
|---|---|---|
| Retrospective (Pre-Intervention) | Participants in this arm were treated for carpal tunnel syndrome before the Carpal Tunnel Plus Pathway was implemented. | |
| Prospective (Post-Intervention) | Participants in this arm were treated for carpal tunnel syndrome after the Carpal Tunnel Plus Pathway was implemented. Receives: Procedure: Changes to the care pathway for carpal tunnel syndrome (The Carpal Tunnel Plus Pathway) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Wait times
Time between each step of the care pathway (e.g. from referral to EMG/neurologic consultation, from referral to surgical consultation, from surgical consultation to surgery)
Measured: From initial referral to surgery/injection (variable, but approximately 9 months)
Patient satisfaction
Patients will be asked to complete a short questionnaire to indicate their level of satisfaction with the care that they received. The custom survey will consist of 4 questions on various aspects of their care that participants will rate on a scale of 1-5 (1 = not at all satisfied, 5 = very satisfied).
Measured: Immediately after surgery/injection appointment
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Dec 2024
- Study start18 Feb 2025
- Primary completionMar 2026 (estimated)
- Study completionMar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Carpal Tunnel Syndrome (CTS)Studies of the same condition, open and under way.
- More trials run by University of British ColumbiaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of British Columbia
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kristine Chapman, University of British Columbia
- Investigators
- Kristine Chapman, Principal investigator, University of British Columbia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06717477
- Sponsor's protocol ID
- H24-03066
- Acronym
- CTS+ Pathway
- Status last verified
- Dec 2025
- First submitted
- 2 Dec 2024
- Last updated
- 26 Dec 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared. Only group averages/summary measures will be included in any publications.
Study at a glance
From the registry record, last updated by the sponsor on 26 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Streamlining Care for Patients With Compression Neuropathies: The Carpal Tunnel Plus Pathway
- ClinicalTrials.gov ID
- NCT06717477
- Acronym / sponsor ID
- CTS+ Pathway / H24-03066
- Conditions
- Carpal Tunnel Syndrome (CTS)
- Keywords
- Carpal Tunnel Syndrome, Patient Satisfaction, Care Pathway
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- University of British ColumbiaUniversity, hospital or other
- Study start
- 18 Feb 2025 (actual)
- Primary completion
- Mar 2026 (estimated)
- Study completion
- Mar 2026 (estimated)
- First posted
- 5 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to assess the impact of a new care pathway (the Carpal Tunnel Plus Pathway) in patients with carpal tunnel syndrome. The main questions it aims to answer are:
- What was the effect of the Carpal Tunnel Plus Pathway on wait times between each step of the care pathway (e.g. from referral to initial consult, from initial consult to surgical consult, etc.)?
- How satisfied are patients with the care they received through the Carpal Tunnel Plus Pathway?
Researchers will compare wait times pre- and post- Pathway implementation to see if there was any change.
Participants will be asked to complete a short patient satisfaction survey.
Study design
- Observational model
- Cohort
- Time perspective
- Other
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Retrospective (Pre-Intervention) | – | –Participants in this arm were treated for carpal tunnel syndrome before the Carpal Tunnel Plus Pathway was implemented. |
| Prospective (Post-Intervention) | – | Procedure: Changes to the care pathway for carpal tunnel syndrome (The Carpal Tunnel Plus Pathway)Participants in this arm were treated for carpal tunnel syndrome after the Carpal Tunnel Plus Pathway was implemented. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Retrospective: Patients age 18 or over seen by study surgeons for CTS. Prospective: patients age 18 or over with carpal tunnel syndrome seen at SPH or Vancouver Hospital EMG lab.
Key inclusion criteria (3 listed)
- 18 years of age or older
- Referred to the Vancouver General Hospital Neuromuscular Disease Unit or St. Paul's Hospital with a confirmed diagnosis of carpal tunnel syndrome
- Ability to understand English
Key exclusion criteria (1 listed)
- Inability to provide informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Changes to the care pathway for carpal tunnel syndrome (The Carpal Tunnel Plus Pathway)Changes to the care pathway for carpal tunnel syndrome. Features of the CTS+ pathway include new referral form, care map for mild, moderate and severe CTS established, point or care ultrasound with steroid injection introduced, and expedited referral to surgeons. | Procedure or surgery | Prospective (Post-Intervention) |
Primary outcome
Wait times
Time frame: From initial referral to surgery/injection (variable, but approximately 9 months)
Time between each step of the care pathway (e.g. from referral to EMG/neurologic consultation, from referral to surgical consultation, from surgical consultation to surgery)
Patient satisfaction
Time frame: Immediately after surgery/injection appointment
Patients will be asked to complete a short questionnaire to indicate their level of satisfaction with the care that they received. The custom survey will consist of 4 questions on various aspects of their care that participants will rate on a scale of 1-5 (1 = not at all satisfied, 5 = very satisfied).
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Dec 2025.
- Website for the Carpal Tunnel Plus PathwayLink provided by the sponsor.
- Individual participant dataSharing planned: No. Individual participant data will not be shared. Only group averages/summary measures will be included in any publications.
Related trials for Carpal Tunnel Syndrome (CTS)
Not yet recruitingObservational study
Postural Control and Balance Performance in Patients With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Postural Assessment
Recruiting
Comparison of Wrist Splint Positions in Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS), Peripheral Neuropathies
Recruiting
Effects of Repetitive Peripheral Magnetic Stimulation(rPMS) on CTS(Carpal Tunnel Syndrome)
Carpal Tunnel Syndrome (CTS)
Recruiting
Hand Function Outcome After the Application of Transfer Energy Capacitive and Resistive on Post-burn Patients Presented With Carpal Tunnel Syndrome
Carpal Tunnel Syndrome (CTS) Post-burn
Not yet recruiting
Effect of Progressive Gamified Motor Rehabilitation After Carpal Tunnel Release
Carpal Tunnel Surgery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Kristine Chapman principal investigator
University of British Columbia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Carpal Tunnel Syndrome (CTS), run by University of British Columbia at 1 site in Canada.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 26 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Wait times (time frame: From initial referral to surgery/injection (variable, but approximately 9 months)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Dec 2025.